Form 4 for MGRX MANGOCEUTICALS, INC.
Accepted 2025-12-11 00:00:00 ET · period of report 2025-12-09 · accession 0001493152-25-027238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-11 | 2025-12-09 | MGRX | JOHNSTON EUGENE M | CFO | S - Sale | $1.20 | -5,000 | 123.3K | -4% | -$6,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-09 | S | D | 5,000 | $1.20 | 123,333 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $1.19 to $1.21, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |